Brief Report: Role of Sociobehavioral Factors in Subprotective TFV-DP Levels Among YMSM Enrolled in 2 PrEP Trials.


Journal

Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005

Informations de publication

Date de publication:
01 02 2019
Historique:
entrez: 15 1 2019
pubmed: 15 1 2019
medline: 31 10 2019
Statut: ppublish

Résumé

Young men who have sex with men (YMSM) experience disparities in HIV acquisition more than any other group. Daily oral pre-exposure prophylaxis (PrEP) with tenofovir/emtricitabine has been shown to effectively prevent HIV transmission in YMSM; however, recent studies suggest that young Black men who have sex with men experience subprotective levels of tenofovir diphosphate more frequently than other groups. Combined data from Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 110/113, 2 open-label PrEP studies that provided PrEP and evidence-based behavioral interventions to YMSM aged 15-22 years. Bivariate and logistic regression analyses were used to examine sociodemographic and behavioral factors associated with protective tenofovir diphosphate levels (defined as ≥700 fmol/punch) in ATN 110/113 data. In bivariate analysis, self-identified Black participants, residential displacement due to sexual orientation, low perceived risk, and stigma with the medication were associated with subprotective levels. Hispanic ethnicity was associated with protective levels. In the final models, Black males were less likely to have subprotective levels than non-Black males at 4, 8, and 12 weeks. Self-reported displacement due to sexual orientation was associated with subprotective levels, whereas older age was as associated with protective levels. These findings highlight how future behavioral research and biomedical prevention efforts in YMSM will need to address PrEP disparities that may occur in young Black men who have sex with men, perception of risk, and lack of key supportive housing during this period that may be critical factors that contribute to HIV acquisition.

Sections du résumé

BACKGROUND
Young men who have sex with men (YMSM) experience disparities in HIV acquisition more than any other group. Daily oral pre-exposure prophylaxis (PrEP) with tenofovir/emtricitabine has been shown to effectively prevent HIV transmission in YMSM; however, recent studies suggest that young Black men who have sex with men experience subprotective levels of tenofovir diphosphate more frequently than other groups.
SETTING
Combined data from Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 110/113, 2 open-label PrEP studies that provided PrEP and evidence-based behavioral interventions to YMSM aged 15-22 years.
METHODS
Bivariate and logistic regression analyses were used to examine sociodemographic and behavioral factors associated with protective tenofovir diphosphate levels (defined as ≥700 fmol/punch) in ATN 110/113 data.
RESULTS
In bivariate analysis, self-identified Black participants, residential displacement due to sexual orientation, low perceived risk, and stigma with the medication were associated with subprotective levels. Hispanic ethnicity was associated with protective levels. In the final models, Black males were less likely to have subprotective levels than non-Black males at 4, 8, and 12 weeks. Self-reported displacement due to sexual orientation was associated with subprotective levels, whereas older age was as associated with protective levels.
CONCLUSIONS
These findings highlight how future behavioral research and biomedical prevention efforts in YMSM will need to address PrEP disparities that may occur in young Black men who have sex with men, perception of risk, and lack of key supportive housing during this period that may be critical factors that contribute to HIV acquisition.

Identifiants

pubmed: 30640203
doi: 10.1097/QAI.0000000000001901
pii: 00126334-201902010-00005
pmc: PMC6486465
mid: NIHMS1510184
doi:

Substances chimiques

Anti-HIV Agents 0
Organophosphates 0
tenofovir diphosphate 0
Adenine JAC85A2161

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

160-165

Subventions

Organisme : NICHD NIH HHS
ID : U01 HD040474
Pays : United States
Organisme : NICHD NIH HHS
ID : U01 HD040533
Pays : United States

Références

PLoS One. 2018 Jul 25;13(7):e0200560
pubmed: 30044845
AIDS Behav. 2017 May;21(5):1236-1246
pubmed: 28108878
Soc Sci Med. 2000 Jun;50(11):1599-605
pubmed: 10795966
J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):528-37
pubmed: 25230290
Pediatr Clin North Am. 2016 Dec;63(6):1091-1106
pubmed: 27865335
J Adolesc Health. 2012 Oct;51(4):386-92
pubmed: 22999840
JAMA Pediatr. 2017 Nov 1;171(11):1041-1042
pubmed: 28873123
PLoS One. 2017 Feb 21;12(2):e0172354
pubmed: 28222118
Lancet Infect Dis. 2014 Sep;14(9):820-9
pubmed: 25065857
Clin Infect Dis. 2018 Mar 5;66(6):936-944
pubmed: 29069298
JAMA Intern Med. 2016 Jan;176(1):75-84
pubmed: 26571482
AIDS Behav. 2017 May;21(5):1376-1382
pubmed: 28238119
JAMA Pediatr. 2017 Nov 1;171(11):1063-1071
pubmed: 28873128
J Adolesc Health. 2016 Dec;59(6):725-728
pubmed: 27720357
Am J Community Psychol. 1993 Aug;21(4):421-48
pubmed: 8192119
AIDS Res Hum Retroviruses. 2013 Feb;29(2):384-90
pubmed: 22935078
N Engl J Med. 2010 Dec 30;363(27):2587-99
pubmed: 21091279
PLoS One. 2013 Jul 26;8(7):e70413
pubmed: 23922989
Addict Behav. 2001 May-Jun;26(3):415-23
pubmed: 11436933
AIDS Behav. 2007 Nov;11(6 Suppl):56-69
pubmed: 17265143
J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):21-29
pubmed: 27632233

Auteurs

Renata Arrington-Sanders (R)

Division of General Pediatrics and Adolescent Medicine, Johns Hopkins School of Medicine, Baltimore, MD.

Craig M Wilson (CM)

Department of Epidemiology, UAB School of Public Health, Birmingham, AL.

Suzanne E Perumean-Chaney (SE)

Department of Biostatistics, The University of Alabama at Birmingham, Birmingham, AL.

Amit Patki (A)

Division of Child and Adolescent Psychiatry, Statistician II, The University of Alabama at Birmingham, Birmingham, AL.

Sybil Hosek (S)

Department of Psychiatry, Stroger Hospital of Cook County, Chicago, IL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH